Evidence map›Paper›PMID 42141052›Full record

ArticleNPJ digital medicine2026

A dynamic risk prediction framework for Alzheimer's disease and related dementias with interpretability.

Xiaoyang Ruan, Shuyu Lu, Sunyang Fu, Jaerong Ahn, Fang Chen, Rui Li, Andrew Wen, Liwei Wang, Ezenwa Onyema, Victoria Tang and 1 more

Abstract read
In one paragraph

Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xiaoyang RuanDepartment of Health Data Science and AI, McWilliams School of Biomedical Informatics, UT Health Houston, Houston, USA.
Shuyu LuDepartment of Health Data Science and AI, McWilliams School of Biomedical Informatics, UT Health Houston, Houston, USA.
Sunyang FuDepartment of Health Data Science and AI, McWilliams School of Biomedical Informatics, UT Health Houston, Houston, USA.
Jaerong AhnDepartment of Health Data Science and AI, McWilliams School of Biomedical Informatics, UT Health Houston, Houston, USA.
Fang ChenDepartment of Health Data Science and AI, McWilliams School of Biomedical Informatics, UT Health Houston, Houston, USA.
Rui LiDepartment of Health Data Science and AI, McWilliams School of Biomedical Informatics, UT Health Houston, Houston, USA.
Andrew WenDepartment of Health Data Science and AI, McWilliams School of Biomedical Informatics, UT Health Houston, Houston, USA.
Liwei WangDepartment of Clinical and Health Informatics, McWilliams School of Biomedical Informatics, UT Health Houston, Houston, USA.
Ezenwa OnyemaDepartment of Internal Medicine, McGovern Medical School, UT Health Houston, Houston, USA.
Victoria TangDepartment of Internal Medicine, McGovern Medical School, UT Health Houston, Houston, USA.
Hongfang LiuDepartment of Health Data Science and AI, McWilliams School of Biomedical Informatics, UT Health Houston, Houston, USA. hongfang.liu@uth.tmc.edu.

Funding

Cancer Prevention and Research Institute of Texas Established Investigator Award RR230020National Institute of Aging R01AG072799-03NHGRI NIH HHS 3R01HG012748-02S2
6 · The paper itself

Abstract

Alzheimer's disease and related dementias (ADRD) develop years before symptoms emerge, making early prediction critical. Electronic health records (EHR) offer a scalable alternative to neuroimaging but are challenged by irregular encounters, data sparsity, and limited interpretability. We propose Gated Recurrent Unit with Decay & Attention (GRU-DA), which integrates GRU-D missingness modeling with RETAIN-style attention for interpretable risk monitoring. The model was trained on the University of Texas Physicians EHR (15,172 ADRD cases with 1:10 matched controls) and externally validated in the All of Us cohort. EHR data up to 10 years before diagnosis were used, with random follow-up initiation to reflect real-world encounters. Both GRU-DA and GRU-D outperformed competing models, particularly beyond 5 years of follow-up and achieved AUROC ~ 0.7 after 8.5 years. Prediction performance depended more on data availability than follow-up length: 1 year with 15% data availability (AUROC 0.75, Average Precision 0.5) was comparable to 7.5 years with 10% availability. For individual cases, GRU-DA produced stable risk predictions with some variability in timestep and feature-level attributions across folds. These results demonstrate EHR data can support dynamic ADRD risk monitoring up to 10 years before diagnosis, with effectiveness strongly influenced by data completeness.

Identifiers

PMID42141052
PMCPMC13260447

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.